naltrexone has been researched along with ecopipam in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Strassburg, CP; Tukey, RH | 1 |
| Acquas, E; Di Chiara, G; Fenu, S; Pisanu, A | 1 |
| Cottone, P; Kwak, J; Rice, KC; Sabino, V | 1 |
1 review(s) available for naltrexone and ecopipam
| Article | Year |
|---|---|
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic | 2000 |
2 other study(ies) available for naltrexone and ecopipam
| Article | Year |
|---|---|
Modulation of Delta(9)-THC-induced increase of cortical and hippocampal acetylcholine release by micro opioid and D(1) dopamine receptors.
Topics: Acetylcholine; Animals; Behavior, Animal; Benzazepines; Dopamine Antagonists; Dronabinol; Drug Interactions; Hippocampus; Male; Microdialysis; Naloxone; Naltrexone; Narcotic Antagonists; Prefrontal Cortex; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Opioid, mu; Time Factors | 2006 |
Pharmacological characterization of the 20% alcohol intermittent access model in Sardinian alcohol-preferring rats: a model of binge-like drinking.
Topics: Alcohol Drinking; Animals; Benzazepines; Binge Drinking; Choice Behavior; Disease Models, Animal; Dopamine Antagonists; Ethanol; Male; Naltrexone; Narcotic Antagonists; Pyrimidines; Rats; Receptors, Corticotropin-Releasing Hormone; Self Administration | 2013 |